Assembly Biosciences Inc (ASMB)

Assembly Biosciences Inc (ASMB) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $409M; returns 1 day -2.2%, 1 week -1.2%, 1 year -27.9%.

Assembly Biosciences Inc. (ASMB) is a clinical-stage biotechnology company primarily focused on the discovery and development of novel small-molecule antiviral therapeutics for serious viral diseases. As of January 2026, its core therapeutic areas include chronic Hepatitis B (HBV), Hepatitis Delta Virus (HDV), and Herpes Simplex Virus (HSV), including recurrent genital herpes.

Groups ASMB belongs to

• Biotechnology
• Clinical Stage Biotech
• Clinical Stage
• Antivirals
• Pharmaceuticals
• Infectious Diseases
• Healthcare
• Life Sciences
• Strategic Partnerships
• R&D

ASMB financial model: income statement, cash flow and balance sheet